临床输血科经血传播相关病原体分子生物学检测规范管理中国专家共识  

Chinese Expert Consensus on Standardized Management of Molecular Biology Detection of Pathogens Related to Blood Transmission in the Clinical Transfusion Department

作　　者：中国输血协会临床输血管理学专业委员会 胡俊华[2,3,4] 吕先萍 李丽玮 马兴焕 张芃 李志强[6] 宫济武 Working Party on Transfusion Management,Chinese Society of Blood Transfusion(CSBT)

机构地区：[1]不详 [2]北京医院 [3]国家老年医学中心 [4]中国医学科学院老年医学研究院 [5]郑州大学第一附属医院 [6]上海交通大学附属第六人民医院 [7]感染性疾病及肿瘤基因诊断技术国家地方联合工程研究中心

出　　处：《现代检验医学杂志》2024年第6期1-10,17,共11页Journal of Modern Laboratory Medicine

摘　　要：为了减少医疗机构院内交叉感染,降低医护人员的职业暴露风险,提高经血传播性疾病溯源性,确保临床输血安全,规避医患纠纷,中国输血协会临床输血管理学专业委员会结合国内外临床研究成果和相关规范指南,召集了临床输血、感染病学等领域的专家共同制定了此专家共识。以期能够规范临床输血科开展经血传播相关病原体分子生物学检测相关规则,降低经血传染性疾病发生率。To reduce nosocomial cross-infection,reduce the occupational exposure risk of medical staff,improve the traceability of transmissible diseases,ensure the safety of clinical blood transfusion,and avoid doctor-patient disputes.The Working Party on Transfusion Management,Chinese Society of Blood Transfusion(CSBT)has convened experts in clinical blood transfusion and infectious diseases to formulate this expert consensus by combining domestic and international clinical research results and relevant norms and guidelines.To standardize the blood transfusion department to carry out molecular biological detection of pathogens related to menstrual transmission,and reduce the incidence of infectious diseases of menstrual blood.

关 键 词：临床输血科 血源性传染病 分子生物学 实验室规范管理 

分 类 号：R457[医药卫生—治疗学]